FDA approves Teva’s once-monthly schizophrenia treatment
One source
What the source said
Israel National News
“FDA approves Teva’s once-monthly schizophrenia treatment”
Israeli pharmaceutical giant Teva receives FDA approval for WELTRUZA, a new long-acting injection for schizophrenia that eliminates the need for daily medication.
Read at Israel National NewsReported by one source so far. It is confirmed when a second, independent source reports the same thing.